查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
遠程患者監護：主要趨勢、區域分析和市場預測 (2023-2027)
市場調查報告書
商品編碼
1186909

遠程患者監護：主要趨勢、區域分析和市場預測 (2023-2027)

Remote Patient Monitoring: Key Trends, Regional Analysis and Market Forecasts 2023-2027
出版日期: | 出版商: Juniper Research Ltd | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2027 年，全球使用遠程患者監護 (RPM) 解決方案的患者總數將達到 1.155 億，佔世界人口的 1.4%。 它從 2023 年的 7500 萬增長了 67%。 目前，醫療保健系統的壓力越來越大，包括缺乏臨床人員和醫院內的空間有限，增加了對替代醫學解決方案的需求。 RPM 允許在壓力過大的醫療機構之外提供護理，從而提高醫護人員的效率。

本報告分析了全球遠程患者監護市場，概述了系統、主要應用領域、總體市場規模趨勢展望（未來 5 年）、部門、地區和行業。我們正在調查市場的詳細趨勢，市場競爭結構，未來增長潛力和挑戰，主要公司概況（共15家公司）等。

回答的主要問題

  • 1. 主要市場趨勢將如何影響遠程患者監護採用預測？
  • 2. 哪些技術將加速遠程患者監控？
  • 3. 誰是遠程患者監護市場的主要供應商？
  • 4. 阻礙遠程患者監測的局限性有哪些？
  • 5. 遠程患者監控在哪些地區最為成功？

主要市場統計數據

2023 年市場規模 720 億美元
2027 年市場規模 1100 億美元
2023 年到 2027 年的增長率 54%

主要特點

  • 基準行業預測：按地區（共 8 個地區）、按國家（共 60 個國家）
    • 北美
      • 加拿大、美國
    • 拉丁美洲
      • 阿根廷、巴西、智利、哥倫比亞、厄瓜多爾、墨西哥、秘魯、烏拉圭
    • 西歐
      • 奧地利、比利時、丹麥、芬蘭、法國、德國、希臘、愛爾蘭、意大利、荷蘭、挪威、葡萄牙、西班牙、瑞典、瑞士、英國
    • 中歐和東歐
      • 克羅地亞、捷克共和國、匈牙利、波蘭、羅馬尼亞、俄羅斯、土耳其、烏克蘭
    • 遠東/中國
      • 中國、香港、日本、韓國
    • 印度次大陸
      • 孟加拉國、印度、尼泊爾、巴基斯坦
    • 其他亞太國家
      • 澳大利亞、印度尼西亞、馬來西亞、新西蘭、菲律賓、新加坡、泰國、越南
    • 非洲/中東
      • 阿爾及利亞、埃及、以色列、肯尼亞、科威特、尼日利亞、卡塔爾、沙特阿拉伯、南非、阿拉伯聯合酋長國

公司分析

  • Juniper Research 競爭對手排行榜公司： Abbott Laboratories、AMC Health、Biotronik、Boston Scientific、Dreger、GE HealthCare、Masimo、MedM、Medtronic、Omron Corporation、Orion Health、Philips、 Qure4u、羅氏、Vivalink
  • 提到的公司：Acutronic、AFVD、AliveCor、Ascom、AWS、BiolntelliSense、Bionet、Bow Medical、Brainlab、Community Wellness、Doctor Anywhere、Dystonia Europe、EPDA、Luscii、Mazzetti、Partners HealthCare、鳳凰城、高通、三星、Triton、大學醫院、Verustat

內容

第 1 部分市場趨勢和策略

第一章要點與策略建議

第二章市場展望

  • 簡介
    • 定義
    • HistoryDe□□vices 用於患者監測
    • 促進遠程患者監控的技術
    • 遠程病人監護中的人工智能
  • 遠程患者監護的優勢
  • 遠程患者監護的缺點
  • 遠程患者監護的驅動因素
  • 遠程患者監測的約束因素

第三章市場細分

  • 簡介
  • 心血管
    • 用於心血管監測的設備類型
    • 用於心血管疾病的遠程醫療的其他方面
    • 智能手錶在心血管疾病中的應用
    • 所需技術的變化和發展
    • 迄今為止的介紹
  • 糖尿病
  • 肥胖
  • 癌症
  • 孕婦
  • 血壓計
  • 胎兒/新生兒

第四章區域分析

  • 簡介
    • 北美
      • 美國
      • 加拿大
    • 拉丁美洲
      • 阿根廷
      • 巴西
    • 西歐
      • 丹麥
      • 法國
      • 德國
      • 英國
    • 中歐和東歐
      • 波蘭
    • 遠東/中國
      • 中國
      • 日本
    • 印度次大陸
      • 印度
    • 其他亞太國家
      • 澳大利亞
      • 新加坡
    • 非洲/中東
      • 沙特阿拉伯
      • 南非

第 2 部分競爭排行榜

第 1 章競爭排行榜和供應商概況

  • 遠程患者監護供應商簡介
    • 雅培實驗室
      • 公司
      • 地區
      • 主要客戶和合作夥伴
      • 主要產品/服務
      • JuniperResearch 洞察：主要優勢和戰略機會
    • AMC Health
    • Biotronik
    • Boston Scientific Corporation
    • Drager
    • Ge HealthCare
    • Masimo
    • MedM
    • Medtronic
    • Omron Corporation
    • Orion Health
    • Philips
    • Qure4u
    • Roche
    • Vivalink
  • Juniper Research 排行榜分析方法

第 3 部分數據和預測

第 1 章介紹/市場概述

第 2 章預測概述

  • 簡介
  • 用戶和收入
    • RPM 用戶總數
    • 正在使用的 RPM 設備總數
    • RPM 總收入
  • 來自各種設備的每千次展示收入
    • RPM 設備帶來的總收入

第 3 章心臟監測市場預測

  • 介紹
  • 預測方法
  • 用戶和收入
    • 使用 RPM 的心髒病患者總數
    • 用於心臟監測的 RPM 設備總數

第 4 章糖尿病監測市場預測

  • 簡介
  • 預測方法
  • 用戶和收入
    • 使用 RPM 的糖尿病患者總數
    • 用於糖尿病監測的 RPM 設備總數

第 5 章腫瘤監測市場預測

  • 簡介
  • 預測方法
  • 用戶和收入
    • 使用 RPM 的癌症患者總數
    • 用於腫瘤監測的 RPM 設備總數

第 6 章肥胖監測市場預測

  • 簡介
  • 預測方法
  • 用戶和收入
    • 使用 RPM 的肥胖患者總數
    • 用於肥胖監測的 RPM 設備總數
簡介目錄

REPORT OVERVIEW

Juniper Research's “Remote Patient Monitoring” report provides a detailed evaluation of the market, including the adoption of remote patient monitoring within both developing markets and established markets. In addition, this report covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward. This report analyses the role of 15 leading remote patient monitoring vendors across the market, evaluating them through a competitor leaderboard.

The research suite also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of remote patient monitoring patients, number of remote patient monitoring devices split by device type, including ECG (Electrocardiogram), blood pressure INR (International Normalised Ratio) test, pulse oximeter, glucose monitor, Bluetooth scale and smartwatches, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue.

Key Market Statistics

Market size in 2023:$72bn
Market size in 2027:$110bn
2023 to 2027 growth:54%

This research suite comprises of:

  • Market Trends & Strategies (PDF)
  • Competitor Leaderboard (PDF)
  • Data & Forecasts (PDF & Excel)
  • 12 Months' Access to harvest Online Data Platform

KEY FEATURES

  • Market Dynamics: A strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of remote patient monitoring, including the following:
    • COVID-19's impact on the remote patient monitoring market.
    • Future strategic direction and market outlook for remote patient monitoring.
    • Key drivers for remote patient monitoring vendors, including nurse shortages and healthcare system struggles.
  • Regional Analysis: A regional-level analysis of 16 countries, spanning 8 key regions; covering the current deployment level and future outlook of remote patient monitoring. Giving readers insight into the markets with the best opportunities for remote patient monitoring.
  • Benchmark Industry Forecasts: Includes forecasts for the total number of remote patient monitoring patients, number of remote patient monitoring devices, total spend on remote patient monitoring hardware and software and total remote patient monitoring revenue. This data is split by device type and our 8 key forecast regions and 60 countries:
  • North America:
    • Canada, US
  • Latin America:
    • Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
  • West Europe:
    • Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK
  • Central & East Europe:
    • Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine
  • Far East & China:
    • China, Hong Kong, Japan, South Korea
  • Indian Subcontinent:
    • Bangladesh, India, Nepal, Pakistan
  • Rest of Asia Pacific:
    • Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam
  • Africa & Middle East:
    • Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates
  • Juniper Research Competitor Leaderboard: Key player capability and capacity assessment for 15 remote patient monitoring vendors:
    • Abbott Laboratories
    • AMC Health
    • Biotronik
    • Boston Scientific Corporation
    • Drager
    • GE Healthcare
    • Masimo
    • MedM
    • Medtronic
    • Omron Corporation
    • Orion Health
    • Philips
    • Qure4u
    • Roche
    • Vivalink

KEY QUESTIONS ANSWERED

  • 1. How will key market trends affect projected remote patient monitoring adoption?
  • 2. What technologies will accelerate remote patient monitoring?
  • 3. Who are the leading vendors in the remote patient monitoring market?
  • 4. What limitations are there holding back remote patient monitoring?
  • 5. What regions will remote patient monitoring be most successful in?

COMPANIES REFERENCED

  • Included in Juniper Research Competitor Leaderboard: Abbott Laboratories, AMC Health, Biotronik, Boston Scientific, Dräger, GE HealthCare, Masimo, MedM, Medtronic, Omron Corporation, Orion Health, Philips, Qure4u, Roche, Vivalink.
  • Mentioned: Acutronic, AFVD, AliveCor, Ascom, AWS, BiolntelliSense, Bionet, Bow Medical, Brainlab, Community Wellness, Doctor Anywhere, Dystonia Europe, EPDA, Luscii, Mazzetti, Partners HealthCare, Phoenix, Qualcomm, Samsung, Triton, University Hospitals, Verustat.

DATA & INTERACTIVE FORECAST

Key Market Forecast Splits

  • Device Type:
    • ECG
    • Blood Pressure INR Test
    • Pulse Oximeter
    • Glucose Monitor
    • Bluetooth Scale
    • Smartwatches
  • Condition:
    • Cardiac
    • Diabetes
    • Cancer
    • Obesity

Metrics include the number of users leveraging remote patient monitoring, the number of devices in use for remote patient monitoring, total spend on remote patient monitoring software and hardware and total remote patient monitoring revenue.

  • Geographical splits: 60 countries
  • Number of tables: Over 205 tables
  • Number of datapoints: Over 140,000 datapoints

harvest: Our online data platform, harvest, contains the very latest market data and is updated throughout the year. This is a fully featured platform enabling clients to better understand key data trends and manipulate charts and tables; overlaying different forecasts within the one chart - using the comparison tool. Empower your business with our market intelligence centre, and receive alerts whenever your data is updated.

Interactive Excels (IFxl): Our IFxl tool enables clients to manipulate both forecast data and charts, within an Excel environment, to test their own assumptions using the interactive scenario tool and compare selected markets side by side in customised charts and tables. IFxls greatly increase a client's ability to both understand a particular market and to integrate their own views into the model.

FORECAST SUMMARY

The total number of patients using RPM solutions will reach 115.5 million globally by 2027; equating to 1.4% of the total population. This is an increase from only 75 million in 2023. This growth of 67% is driven by greater pressure on healthcare systems, including clinical staff shortages and limited space within hospitals, driving the need for alternative healthcare solutions. RPM enables care to be moved outside of overstressed healthcare facilities; boosting healthcare providers' efficiency.

  • By 2027, there will be 90 million cardiac patients using RPM solutions. Given the high global prevalence of cardiac conditions, the report recommended that healthcare providers use RPM solutions to monitor the heart rate and blood pressure of cardiac patients at home to lower the number of patients in hospital. RPM solutions will also indirectly decrease disease transmission rates and alleviate pressure on healthcare systems by reducing the demand for hospital beds.
  • Healthcare service providers should fully leverage the data generated by the increase in adoption of RPM devices. To maximise the benefits, it recommended that RPM services fully incorporate AI within their solutions to enable healthcare professionals to improve the efficiency of medical triage processes through a predictive proactive healthcare provision model.

Table of Contents

1. Market Trends & Strategies

1. Key Takeaways & Strategic Recommendations

  • 1.1. Key Takeaways & Strategic Recommendations
  • 1.2. Strategic Recommendations

2. Future Market Outlook

  • 2.1. Introduction
    • Figure 2.1: Visualisation of Elements in eHealth
    • 2.1.1. Definitions
      • Figure 2.2: Diagram Displaying How Remote Patient Monitoring Works
    • 2.1.2. Devices Used in Remote Patient Monitoring
      • i. Blood Pressure Cuff
      • ii. Glucose Monitoring
        • Figure 2.3: Visualisation of Continuous Glucose Monitor
      • iii. Electrocardiography Devices
      • iv. Heart Rate Monitors
      • v. Fall Detection
      • vi. Smart Scales
        • Figure 2.4: Visualisation of RPM Process Containing Devices Used
    • 2.1.3. Technology Driving Remote Patient Monitoring
      • i. Cellular RPM devices
      • ii. Bluetooth Remote Patient Monitoring Devices
    • 2.1.4. Artificial Intelligence in Remote Patient Monitoring
  • 2.2. Benefits of Remote Patient Monitoring
    • 2.2.1. Patient Benefits
      • Figure 2.5: Patient Benefits for Remote Patient Monitoring
      • i. Detailed Information on Personalised Health
      • ii. Faster and Better Access to Healthcare Services
      • iii. Patient Outcomes
      • iv. Comfort in Patients' Own Home
      • v. Better Healthcare Opportunities in Rural Communities
      • vi. Greater Oversight and Communications
    • 2.2.2. Healthcare Professional and Provider Benefits
      • Figure 2.6: Provider Benefits for Remote Patient Monitoring
      • i. Improved Patient Outcomes
      • ii. Lower Costs
      • iii. Free Up Spaces in Hospitals
      • iv. Reduced Risk of Disease Transmission
      • v. Combats Clinical Staff Shortages and Optimises Operations
      • vi. Improves Clinical Decision Making
  • 2.3. Disadvantages within Remote Patient Monitoring
    • 2.3.1. Disadvantages of Remote Patient Monitoring for Patients
      • Figure 2.7: Patient Disadvantages for Remote Patient Monitoring
      • i. Patient Isolation
      • ii. Privacy
      • iii. Requires Some Knowledge Surrounding Technology
    • 2.3.2. Disadvantages of Remote Patient Monitoring for Healthcare Providers
      • Figure 2.8: Provider Disadvantages for Remote Patient Monitoring
      • i. Over-reliance on Data
      • ii. Not Consistent Real-Time Monitoring
      • iii. Error Rates of Existing RPM
  • 2.4. Drivers of Remote Patient Monitoring
  • 2.5. Barriers to Remote Patient Monitoring

3. Market Segments

  • 3.1. Introduction
  • 3.2. Cardiovascular
    • 3.2.1. Types of Devices Used for Cardiovascular Monitoring
      • i. Blood Pressure Monitor
      • ii. Anticoagulation Testing Devices
        • Figure 3.1: Image Displaying a INR Testing Device
      • iii. ECG devices
        • Figure 3.2: Visualisation of the Kardia Mobile 6L App and Electrode
      • iv. Pulse Oximetry
    • 3.2.2. Other Aspects of Telemedicine Used in Cardiovascular Diseases
    • 3.2.3. The Use of Smartwatches in Cardiovascular Diseases
    • 3.2.4. Changes and Developments in Technology Required
    • 3.2.5. Deployments to Date
      • Figure 3.3: Total Number of Cardiac Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.3. Diabetes
    • 3.3.1. Types of Devices Used for Diabetes Monitoring
      • i. Continuous Glucose Monitor
        • Figure 3.4: Visualisation of Continuous Glucose Monitor
      • ii. Smart Insulin Pen
        • Figure 3.5: Visualisation of Smart Insulin Pen
      • iii. Ketone Monitors
    • 3.3.2. Other Aspects of Telemedicine Used in Diabetes
      • Figure 3.6: Visualisation of Dexcom Clarity
    • 3.3.3. The Use of Smartwatches in Diabetes
    • 3.3.4. Changes and Developments in Technology Required
    • 3.3.5. Deployments to Date
      • Figure 3.7: Total Number of Diabetic Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.4. Obesity
    • 3.4.1. Types of Devices Used for Obesity Management
      • i. Smart Scales
        • Figure 3.8: Visualisation of Smart Scales
      • ii. Blood Pressure Monitors
    • 3.4.2. Other Aspects of Telemedicine in Obesity Monitoring
    • 3.4.3. The Use of Smartwatches in Obesity Monitoring
    • 3.4.4. Changes and Developments Required in Technology
    • 3.4.5. Deployments to Date
      • Figure 3.9: Total Number of Obesity Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.5. Cancer
    • 3.5.1. Types of Devices Used for Cancer Management
      • i. Digital Thermometer
        • Figure 3.10: Visualisation of TempTraq in Remote Patient Monitoring
    • 3.5.2. Other Aspects of Telemedicine in Cancer Management
    • 3.5.3. The Use of Smartwatches in Cancer Management
    • 3.5.4. Changes and Developments Required in Technology
    • 3.5.5. Deployments to Date
      • Figure 3.11: Total Number of Cancer Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
  • 3.6. Maternity
    • Table 3.12: Vital Sign Uses in Tracking Maternity Clinical Implications
    • 3.6.1. Types of Devices Used for Maternity Management
      • i. Blood Pressure Monitors
    • 3.6.2. Other Aspects of Telemedicine in Maternity Management
      • Figure 3.13: Telemedicine Uses Within Pregnancy
    • 3.6.3. Use of Smartwatches in Maternity Management
    • 3.6.4. Changes and Developments Required in Technology
    • 3.6.5. Deployments to Date
  • 3.7. Foetal and Neonatal
    • 3.7.1. Types of Devices Used for Foetal and Neonatal Management
    • 3.7.2. Other Aspects of Telemedicine in Foetal and Neonatal Management
    • 3.7.3. The Use of Smartwatches in Foetal and Neonatal Management
    • 3.7.4. Changes and Developments Required in Technology
    • 3.7.5. Deployments to Date

4. Regional Analysis

  • 4.1. Introduction
    • 4.1.1. North America
      • i. US
        • Table 4.1: Key Health Metrics, 2020-2022 US
      • ii. Canada
        • Table 4.2: Key Health Metrics, 2020-2022 Canada
    • 4.1.2. Latin America
      • i. Argentina
        • Table 4.3: Key Health Metrics, Argentina, 2020-2022
      • ii. Brazil
        • Table 4.4: Key Health Metrics, 2020-2022, Brazil
    • 4.1.3. West Europe
      • i. Denmark
        • Table 4.5: Key Health Metrics, 2020-2022, Denmark
      • ii. France
        • Table 4.6: Key Health Metrics, 2020-2022, France
      • iii. Germany
        • Table 4.7: Key Health Metrics, 2020-2022, Germany
      • iv. UK
        • Table 4.8: Key Health Metrics, 2020-2022, UK
    • 4.1.4. Central & East Europe
      • i. Poland
        • Table 4.9: Key Health Metrics, 2020-2022, Poland
    • 4.1.5. Far East & China
      • i. China
        • Table 4.10: Key Health Metrics, 2020-2022, China
      • ii. Japan
        • Table 4.11: Key Health Metrics, 2020-2022, Japan
    • 4.1.6. Indian Subcontinent
      • i. India
        • Table 4.12: Key Health Metrics, 2020-2022, India
    • 4.1.7. Rest of Asia Pacific
      • i. Australia
        • Table 4.13: Key Health Metrics, 2020-2022, Australia
      • ii. Singapore
        • Table 4.14: Key Health Metrics, 2020-2022, Singapore
    • 4.1.8. Africa & Middle East
      • i. Saudi Arabia
        • Table 4.15: Key Health Metrics, 2020-2022, Saudi Arabia
      • ii. South Africa
        • Table 4.16: Key Health Metrics, 2020-2022, South Africa

2. Competitor Leaderboard

1. Competitor Leaderboard & Vendor Profiles

  • Table 1.1: Juniper Research Competitor Leaderboard: Remote Patient Monitoring Vendors Included & Product Portfolio
  • Figure 1.2: Juniper Research Leaderboard: Remote Patient Monitoring Vendors
  • Table 1.3: Juniper Research Leaderboard: Remote Patient Monitoring Vendors Positioning
  • Table 1.4: Juniper Research Leaderboard Heatmap: Remote Patient Monitoring
  • 1.1. Remote Patient Monitoring Vendor Profiles
    • 1.1.1. Abbott Laboratories
      • i. Corporate
        • Table 1.5: Abbott Laboratories' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.6: Visualisation of the Abbott Laboratories' RPM Solution
        • Figure 1.7: Visualisation of the LibreView Process
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.2. AMC Health
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.3. Biotronik
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.8: Biotronik's Remote Patient Monitoring Solution
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.4. Boston Scientific Corporation
      • i. Corporate
        • Table 1.9: Boston Scientific's Financial Snapshot ($b), FY 2019-2021
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.10: Visualisation Showing Boston Scientific's Heart Connect System
        • Figure 1.11: Visualisation of Boston Scientific's Latitude Programming System
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.5. Drager
      • i. Corporate
        • Table 1.12: Dräger's Financial Snapshot ($b), FY 2020-2021
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.13: Visualisation of Dräger's Infinity Gateway Suite
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.6. Ge HealthCare
      • i. Corporate
        • Table 1.14: GE HealthCare's Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.15: Visualisation of GE HealthCare's Mural Virtual Clinical Viewer
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.7. Masimo
      • i. Corporate
        • Table 1.16: Masimo's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.17: Visualisation of Replica Smart Patient Data Management
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.8. MedM
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.18: Visualisation of MedM RPM Software
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.9. Medtronic
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.19: Visualisation of Medtronic Remote Patient Monitoring
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.10. Omron Corporation
      • i. Corporate
        • Table 1.20: Omron's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
      • iii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.21: Visualisation of Omron VitalSight
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.11. Orion Health
      • i. Corporate
        • Table 1.22: Orion Health's Financial Snapshot ($m), FY2020-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.12. Philips
      • i. Corporate
        • Table 1.23: Philips' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.24: Visualisation of Philip's Enterprise Telehealth Solutions
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.13. Qure4u
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.25: Visualisation of Qure4u's Remote Patient Monitoring Solution
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.14. Roche
      • i. Corporate
        • Table 1.26: Roche's Financial Snapshot ($b), FY 2020-2021 (FYE 31st December)
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
    • 1.1.15. Vivalink
      • i. Corporate
      • ii. Geographic Spread
      • iii. Key Clients & Strategic Partnerships
      • iv. High-level View of Offerings
        • Figure 1.27: Visualisation of Vivalink Wearable SP02 Sensor
      • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.2. Juniper Research Leaderboard Assessment Methodology
    • 1.2.1. Limitations & Interpretations
      • Table 1.28: Juniper Research Competitor Leaderboard Scoring Criteria

3. Data & Forecasting

1. Introduction & Market Summary

  • 1.1. Introduction
    • Figure 1.1: Visualisation of Elements in eHealth
    • 1.1.1. Definitions
      • Figure 1.2: Diagram Displaying how Remote Patient Monitoring Works

2. Forecast Summary

  • 2.1. Introduction
  • 2.2. Users & Revenue
    • 2.2.1. Total Number of RPM Users
      • Figure & Table 2.1: Total Number of RPM Users (m), Split by 8 Key Regions, 2022-2027
    • 2.2.2. Total Number of RPM Devices in Use
      • Figure & Table 2.2: Total Number of RPM Devices (m), Split by 8 Key Regions, 2022-2027
    • 2.2.3. Total RPM Revenue
      • Figure & Table 2.3: Total RPM Revenue ($m), Split by 8 Key Regions, 2022-2027
  • 2.3. RPM Revenue from Each Device
    • 2.3.1. Total Revenue from RPM Devices
      • We expect the total annual revenue from people using RPM to reach $110.3 billion in 2027, up from $71.7 billion in 2023; a CAGR of 13.18% across the forecast period.
      • Figure & Table 2.4: Total Number of RPM devices, Split by 7 Devices, 2022-2027

3. Cardiac Monitoring Market Forecasts

  • 3.1. Introduction
  • 3.2. Forecast Methodology
    • 3.2.1. Users & Revenue Forecast Methodology
      • Figure 3.1: Cardiac Patient RPM Users & Devices Forecast Methodology
  • 3.3. Users & Revenue
    • 3.3.1. Total Number of Cardiac Patients using RPM
      • Figure & Table 3.2: Total Number of Cardiac Patients using RPM (m), Split by 8 Key Regions, 2022-2027
    • 3.3.2. Total Number of RPM Devices Used for Cardiac Monitoring
      • Figure & Table 3.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

4. Diabetes Monitoring Market Forecasts

  • 4.1. Introduction
  • 4.2. Forecast Methodology
    • 4.2.1. Users & Revenue Forecast Methodology
      • Figure 4.1: Diabetic Patient RPM Users & Devices Forecast Methodology
  • 4.3. Users & Revenue
    • 4.3.1. Total Number of Diabetic Patients Using RPM
      • Figure & Table 4.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 4.3.2. Total Number of RPM Devices Used for Diabetic Monitoring
      • Figure & Table 4.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

5. Oncology Monitoring Market Forecasts

  • 5.1. Introduction
  • 5.2. Forecast Methodology
    • 5.2.1. Users & Revenue Forecast Methodology
      • Figure 5.1: Cancer Patient RPM Users & Devices Forecast Methodology
  • 5.3. Users & Revenue
    • 5.3.1. Total Number of Cancer Patients Using RPM
      • Figure & Table 5.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 5.3.2. Total Number of RPM Devices Used for Cancer Monitoring
      • Figure & Table 5.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

6. Obesity Monitoring Market Forecasts

  • 6.1. Introduction
  • 6.2. Forecast Methodology
    • 6.2.1. Users & Revenue Forecast Methodology
      • Figure 6.1: Obesity Patient RPM Users & Devices Forecast Methodology
  • 6.3. Users & Revenue
    • 6.3.1. Total Number of Obesity Patients Using RPM
      • Figure & Table 6.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
    • 6.3.2. Total Number of RPM Devices Used for Obesity Monitoring
      • Figure & Table 6.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027